Drug Shortage Report for KADIAN
| Report ID | 139603 |
| Drug Identification Number | 02184435 |
| Brand name | KADIAN |
| Common or Proper name | MORPHINE SULFATE |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 20MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-07-21 |
| Actual start date | 2021-06-23 |
| Estimated end date | 2021-08-24 |
| Actual end date | 2021-07-26 |
| Shortage status | Resolved |
| Updated date | 2021-07-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2021-07-28 | French | Compare |
| v7 | 2021-07-28 | English | Compare |
| v6 | 2021-06-30 | French | Compare |
| v5 | 2021-06-30 | English | Compare |
| v4 | 2021-05-27 | French | Compare |
| v3 | 2021-05-27 | English | Compare |
| v2 | 2021-05-19 | French | Compare |
| v1 | 2021-05-19 | English | Compare |
Showing 1 to 8 of 8